In the last trading session, 0.55 million Tscan Therapeutics Inc (NASDAQ:TCRX) shares changed hands as the company’s beta touched 0.94. With the company’s per share price at $7.11 changed hands at -$0.02 or -0.21% during last session, the market valuation stood at $310.43M. TCRX’s last price was a discount, traded about -26.58% off its 52-week high of $9.00. The share price had its 52-week low at $1.62, which suggests the last value was 77.22% up since then. When we look at Tscan Therapeutics Inc’s average trading volume, we note the 10-day average is N/A shares, with the 3-month average coming to 163.50K.

Tscan Therapeutics Inc (NASDAQ:TCRX) trade information

Instantly TCRX was in red as seen at the end of in last trading. With action -1.59%, the performance over the past five days has been red. The drop to weekly highs of 8.12 on N/A, N/A subtracted -0.21% to the stock’s daily price. The company’s shares are showing year-to-date upside of 22.04%, with the 5-day performance at -1.59% in the red. However, in the 30-day time frame, Tscan Therapeutics Inc (NASDAQ:TCRX) is 4.17% up. Looking at the short shares, we see there were N/A shares sold at short interest cover period of N/A days.

Tscan Therapeutics Inc (TCRX) estimates and forecasts

Data shows that the Tscan Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 101.56% over the past 6 months, a 23.53% in annual growth rate that is considerably higher than the industry average of 12.80%. Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -25.53%. The 2024 estimates are for Tscan Therapeutics Inc earnings to increase by 22.65%.